Ensuring safety and consistency in cell culture production processes: Viral screening and inactivation

This publication has 14 references indexed in Scilit:

• Size Exclusion Removal of Model Mammalian Viruses Using a Unique Membrane System, Part I: Membrane Qualification
  Biologicals, 1993
• Insufficient Inactivation of HIV-1 in Human Cryo Poor Plasma by Beta-propiolactone: Results from a Highly Accurate Virus Detection Method
  Biologicals, 1993
• Contamination of Genetically Engineered CHO-cells by Epizootic Haemorrhagic Disease Virus (EHDV)
  Biologicals, 1993
• Validation of Virus Inactivation and Removal for the Manufacturing Procedure of Two Immunogiobulins and a 5% Serum Protein Solution Treated with β-Propiolactone
  Biologicals, 1993
• Note for guidance: Guidelines for minimizing the risk of transmitting agents causing spongiform encephalopathy via medicinal products
  Biologicals, 1992
• Note for guidance: Validation of virus removal and inactivation procedures
  Biologicals, 1991
• Note for guidance Production and quality control of human monoclonal antibodies
  Biologicals, 1991
• Endogenous origin of defective retroviruslike particles from a recombinant Chinese hamster ovary cell line
  Virology, 1991
• Is Rodent Virus Contamination of Monoclonal Antibody Preparations for Use in Human Therapy a Hazard?
  Journal of General Virology, 1986
• PARVOVIRUS INFECTIONS AND HYPOPLASTIC CRISIS IN SICKLE-CELL ANAEMIA
  The Lancet, 1981